BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
K. Debiec, J. Wydmanski. Introduction to Cancer Metastasis2017; : 137 doi: 10.1016/B978-0-12-804003-4.00008-6
2
E. Van Cutsem, K. Muro, D. Cunningham, G. Bodoky, A. Sobrero, S. Cascinu, J. Ajani, S.C. Oh, S.E. Al-Batran, Z.A. Wainberg, S.R. Wijayawardana, S. Melemed, D. Ferry, R.R. Hozak, A. Ohtsu. Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 studyEuropean Journal of Cancer 2020; 127: 150 doi: 10.1016/j.ejca.2019.10.026
3
Daniela Cornelia Lazăr, Sorina Tăban, Marioara Cornianu, Alexandra Faur, Adrian Goldiş. New advances in targeted gastric cancer treatmentWorld Journal of Gastroenterology 2016; 22(30): 6776-6799 doi: 10.3748/wjg.v22.i30.6776
4
Binay Kumar Shah, Amit Khanal, Yvonne Hewett. Second Primary Malignancies in Adults with Gastric Cancer – A US Population-Based StudyFrontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00082
5
Shuqin Jia, Tingting Qu, Xiaohong Wang, Mengmeng Feng, Yang Yang, Xuemin Feng, Ruiting Ma, Wenmei Li, Ying Hu, Yi Feng, Ke Ji, Ziyu Li, Wenguo Jiang, Jiafu Ji, Aamir Ahmad. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancerPLOS ONE 2017; 12(4): e0175058 doi: 10.1371/journal.pone.0175058
6
Yangyang Wang, Jiping Zeng, Jianyong Pan, Xue Geng, Yansong Liu, Jing Wu, Ping Song, Ying Wang, Jihui Jia, Lixiang Wang. MicroRNA-200c is involved in proliferation of gastric cancer by directly repressing p27 Kip1Biochemistry and Biophysics Reports 2016; 8: 227 doi: 10.1016/j.bbrep.2016.09.007
7
Yung-Jue Bang, Toshimi Takano, Chia-Chi Lin, Adedigbo Fasanmade, Huyuan Yang, Hadi Danaee, Takayuki Asato, Thea Kalebic, Hui Wang, Toshihiko Doi. TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 StudyCancer Research and Treatment 2018; 50(2): 398 doi: 10.4143/crt.2017.074
8
Roy S Herbst, Hendrik-Tobias Arkenau, Rafael Santana-Davila, Emiliano Calvo, Luis Paz-Ares, Philippe A Cassier, Johanna Bendell, Nicolas Penel, Matthew G Krebs, Juan Martin-Liberal, Nicolas Isambert, Andres Soriano, Martin Wermke, Jennifer Cultrera, Ling Gao, Ryan C Widau, Gu Mi, Jin Jin, David Ferry, Charles S Fuchs, Daniel P Petrylak, Ian Chau. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trialThe Lancet Oncology 2019; 20(8): 1109 doi: 10.1016/S1470-2045(19)30458-9
9
Yu-Chang Chuang, Hsin-Yi Wu, Yu-Ling Lin, Shey-Cherng Tzou, Cheng-Hsun Chuang, Ting-Yan Jian, Pin-Rong Chen, Yuan-Ching Chang, Chi-Hsin Lin, Tse-Hung Huang, Chao-Ching Wang, Yi-Lin Chan, Kuang-Wen Liao. Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric CancerBiological Procedures Online 2018; 20(1) doi: 10.1186/s12575-018-0073-x
10
A. Scott Paulson, Lisa M. Hess, Astra M. Liepa, Zhanglin Lin Cui, Kathleen M. Aguilar, Jamyia Clark, William Schelman. Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practicesGastric Cancer 2018; 21(5): 831 doi: 10.1007/s10120-018-0796-z